Characteristic | Continuers (n = 6) | Discontinuers (n = 8) | Total (n = 14) |
---|---|---|---|
Mean age at data collection (years ± SD) | 47.8 (± 8.1) | 40.8 (± 12.1) | 43.8 (± 10.8) |
Female gender (%) | 2(16.7) | 4 (50) | 6 (35.7) |
Mean clozapine dose (mg ± SD) | 362.5 (± 106.9) | 325 (± 73.2) | 341.1 (± 87.5) |
Mean duration of treatment of metoclopramide (years ± SD) | 1.9 (± 1.5) | 0.7 (± 0.9) | 1.2 (± 1.3) |
Mean metoclopramide dose (mg ± SD) | 21.7 (± 7.5) | 18.8 (± 9.9) | 20 (± 8.8) |
Median metoclopramide dose (IQR) | 20 (10) | 15 (20) | 20 (20) |
Metoclopramide monotherapy % | 5 (83.3) | 3 (37.5) | 8 (57.1) |
Adverse reactions reported (%) | 2 (33.3) | 3 (37.5) | 5 (35.7) |